About VectyraBio
Vectyra Biotechnology was founded on providing advanced viral vector solutions: recombinant RNA virus engineering and replication-deficient virus construction to client specification.
As we worked closely with our clients, demand emerged for high-quality, cost-effective cell culture media, organoid and 3D culture systems, reagents and consumables. We expanded into those adjacent areas, building a more complete supply solution for the research community.
Today we supply laboratories and research institutions across both pillars, catalogue products and research services, and we continue to deepen our technical capability to support a rapidly evolving cell and gene therapy landscape.
MIT · Oxford University · New York University · Boston University
Professional background across
Our Competitive Edge
Less vendor management overhead, more time on the science.
| Dimension | Traditional approach | The VectyraBio advantage |
|---|---|---|
| Reagent sourcing | Multiple vendors, fragmented ordering | One platform, one account, one invoice |
| Service integration | Separate CROs for plasmids, viral vectors and organoids | A single provider across all three platforms |
| Scientific support | Generic customer service | PhD-level scientists as your direct contacts |
| Quality transparency | Variable documentation | Full QC reports with every order |
Our Lab
We operate a BSL-2 production facility delivering end-to-end viral vector services, covering construct design, packaging, purification, titration and stable cell line construction.
A selection of the research groups we work with
